Basit öğe kaydını göster

Vitamin D Receptor (VDR) Polymorphisms in Pediatric Patients Presenting With Hodgkin's Lymphoma

dc.contributor.authorBozkurt, Ceyhun
dc.contributor.authorSahin, Gurses
dc.contributor.authorTanyildiz, Hikmet Gülşah
dc.contributor.authorTekgunduz, Sibel A.
dc.contributor.authorYesil, Sule
dc.contributor.authorOren, Ayse C.
dc.contributor.authorCandir, Mehmet O.
dc.date.accessioned2023-02-21T07:51:08Z
dc.date.available2023-02-21T07:51:08Z
dc.date.issued2017
dc.identifier.citationTekgunduz S. A., Yesil S., Oren A. C., Tanyildiz H. G., Candir M. O., Bozkurt C., Sahin G., "Vitamin D Receptor (VDR) Polymorphisms in Pediatric Patients Presenting With Hodgkin's Lymphoma", JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, cilt.39, sa.2, 2017
dc.identifier.issn1077-4114
dc.identifier.otherav_0f1d80e3-2aa9-4aa1-ac15-aca94d5b2f57
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/186171
dc.identifier.urihttps://doi.org/10.1097/mph.0000000000000664
dc.description.abstractVitamin D receptor (VDR) polymorphisms are found more commonly in some tumor types than in healthy individuals, suggesting that some polymorphisms (Cdx2, Fok1, Bsm1, Apa1, Taq1) contribute to tumor development. There is no previous report on VDR polymorphism in Hodgkin's lymphoma (HL) patients. VDR polymorphism patterns in 95 pediatric HL cases with 100 healthy controls were compared. No statistically significant difference was found between the patient group and control group in terms of Cdx2, Fok1, Bsm1, Apa1, and Taq1 polymorphisms (P > 0.5). Our findings suggest that VDR polymorphisms may not play a role in HL development.
dc.language.isoeng
dc.subjectPediatri, Perinatoloji ve Çocuk Sağlığı
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectPEDİATRİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectPediatri
dc.titleVitamin D Receptor (VDR) Polymorphisms in Pediatric Patients Presenting With Hodgkin's Lymphoma
dc.typeMakale
dc.relation.journalJOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
dc.contributor.departmentDr Sami Ulus Matern & Children Res Training Hosp , ,
dc.identifier.volume39
dc.identifier.issue2
dc.contributor.firstauthorID3443611


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster